Updates on the Management of Advanced Hepato-pancreato-biliary Malignancies
Updates on the Management of Advanced Hepato-pancreato-biliary Malignancies: A Report from the 14th European Cancer Conference (ECCO) Introduction The 14th European Cancer Conference of the European...
View ArticleDifferences in IMRT Radiation Doses May Complicate Study Results in Liver Cancer
Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison studies in liver cancer difficult to...
View ArticleNexavar® Effective for Hepatocellular Carcinoma in Asians
Nexavar® Effective for Hepatocellular Carcinoma in Asians Researchers from 23 medical centers in Asia have reported that Nexavar® (sorafenib) is effective in patients with advanced hepatocellular...
View ArticleAvastin® plus Tarceva® Shows Promise in Advanced Hepatocellular Carcinoma
Avastin® plus Tarceva® Shows Promise in Advanced Hepatocellular Carcinoma According to the results of a Phase II clinical trial, the combination of two targeted therapies-Avastin® (bevacizumab) and...
View ArticleSutent® Not Effective for Advanced Liver Cancer
In a Phase II clinical trial, patients with inoperable, advanced hepatocellular (liver) cancer did not benefit from treatment with the targeted therapy Sutent® (sunitinib). The results of this study...
View ArticleCombination Chemotherapy Improves Survival with Biliary Tract Cancer
According to the results of a Phase III clinical trial, treatment of locally advanced or metastatic biliary tract cancer with a combination of Gemzar® (gemcitabine) and cisplatin results in better...
View ArticleNexavar Superior to Sutent in Liver Cancer
Nexavar® (sorafenib) provides superior overall survival to Sutent® (sunitinib) in the treatment of hepatocellular (liver) cancer. These results were presented at the 2011 annual American Society of...
View ArticleClik here to view.
CancerConnect Live Web Chat with Dr. Boris Kuvshinoff II and Dr. Renuka Iyer...
Boris Kuvshinoff II, MD, MBA Treatment Options for Patients with Liver Cancer: Web Chat with Boris Kuvshinoff II, MD, MBA and Renuka Iyer, MD Drs. Kuvshinoff and Iyer are Co-Directors of the Liver and...
View ArticleClik here to view.
Today at 6 PM EST Watch CancerConnect Web Chat with the Experts on Liver Cancer
Boris Kuvshinoff II, MD, MBA Treatment Options for Patients with Liver Cancer: Web Chat with Boris Kuvshinoff II, MD, MBA and Renuka Iyer, MD, March 20th at 6 PM EST Drs. Kuvshinoff and Iyer are...
View ArticleAntiviral Therapy May Reduce the Risk of Tumor Recurrence in HBV-Related...
Patients with hepatitis B-related liver cancer who receive antiviral drugs after curative surgery have a lower risk of recurrence compared to those who do not receive antiviral therapy, according to...
View Article
